This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
For the one-in-five Americans with a mental health condition, the options for treatment aren't too much different from what they were half a century ago. Most medicines for psychiatric disorders were first pioneered in the 1950s.
But new research from Boston University offers fresh insight on a class of drugs many hope can provide new relief for those suffering from depression and anxiety: psychedelics. The study found that psychedelics can improve certain decisions.
In the study, published in Science Advances, researchers trained mice to use sensory cues, pulses of light, to identify which of two sites held a reward. Untreated mice performed the task moderately well but made mistakes, such as returning to the same location regardless of the cues. After receiving psilocybin or ketamine, mice performed better, making fewer mistakes by relying less on habits and more on the relevant sensory cues.
While psychedelics have shown promise, how they alter the brain to produce their therapeutic and mind-altering effects is poorly understood. "These findings reveal how psychedelics reduce the reliance on habits and repetitive choices, which may explain part of their therapeutic effect," says Benjamin Scott, a BU College of Arts & Sciences assistant professor in the department of psychological and brain sciences who co-led the study with Steve Ramirez, an associate professor in the department of psychological and brain sciences.
Source link







